Mylan Loses Bid To Toss Daiichi Benicar Patent
A federal appeals court has upheld an injunction banning Mylan Pharmaceuticals Inc. from making generic versions of Daiichi Sankyo Co. Ltd.'s Benicar and Azor until a patent for the hypertension drugs...To view the full article, register now.
Already a subscriber? Click here to view full article